carnitine · levocarnitine · L-carnitine-L-tartrate · acetyl-L-carnitine
1000 mg · gluten-free · 30 caps
Affiliate link · we earn from qualifying purchases. No paid placements.
L-carnitine is an amino acid derivative synthesized in the liver and kidneys from lysine and methionine. It is essential for transporting long-chain fatty acids into mitochondria for beta-oxidation and ATP production. Dietary sources include red meat, dairy, and fish.
L-carnitine facilitates fatty acid transport across the mitochondrial membrane via the carnitine shuttle system. It also buffers acetyl-CoA, improves glucose oxidation, and may enhance cardiac energy metabolism in ischemic conditions.
Adults with carnitine deficiency, individuals with fatigue or exercise intolerance, those recovering from myocardial infarction (contested), vegetarians and vegans (lower dietary intake), older adults with reduced synthesis.
People with kidney disease (reduced clearance), those with hypothyroidism (may worsen symptoms), individuals with seizure disorders (theoretical concern), pregnant or breastfeeding women (insufficient safety data).
Pick a depth — minimum to maximal coverage
No full stack configured.
Click individual supplement pills above to buy each on Amazon India.
✓ Morning for energy metabolism; pre-workout for exercise performance
✓ Food improves absorption; take with carbohydrate-containing meal
L-carnitine facilitates fatty acid transport across the mitochondrial membrane via the carnitine shuttle system.
Each bar = one cited trial. Effect varies by methodology, dose, and population.
Insomnia cohort (n≈60, PSQI scale)
PSQI score <5 = good sleep quality. Lower is better.
see study
→ Meta-analysis: L-carnitine reduced all-cause mortality by 27%, ventricular arrhythmias by 65%, angina by 40% post-MI (N=13 trials)
see study
→ TMAO mechanism: gut bacteria metabolize carnitine to TMAO, which promotes atherosclerosis in mice and correlates with CVD in humans
see study
→ Meta-analysis: L-carnitine improved cardiac function and exercise tolerance in heart failure (N=17 trials)
B · Strong cardiac meta-analysis data post-MI; TMAO mechanism raises cardiovascular concern in healthy populations; vegetarian gut microbiome produces less TMAO; context-dependent risk-benefit
A plain-English read of the literature behind this supplement. Not a clinical recommendation.
Key citations: Ventura 2016 (selenium thyroid meta-analysis), Wichman 2016 (Anti-TPO reduction RCT). richResearch section contains study filters.
How to use L-Carnitine specifically for fatigue — the right dose, timing, blood markers to track, and how to know if it is working.
A clinical evidence review of L-Carnitine — RCT data, effect sizes, evidence grade, and what the numbers mean for your specific situation.
Everything you need to know about L-Carnitine — mechanism, dose, safety, buying guide for India, and what the research actually says.
SacredBod's longer take on L-Carnitine — context the structured blocks above don't capture.
L-carnitine is the most scientifically contested supplement in the metabolic category. On one hand, meta-analyses demonstrate significant mortality reduction after myocardial infarction and improved cardiac function in heart failure. On the other hand, mechanistic studies link carnitine-derived TMAO (trimethylamine N-oxide) to accelerated atherosclerosis. This tension between clinical outcome data and biomarker-based risk exemplifies the complexity of modern supplement science.
The cardiac evidence is genuinely impressive. DiNicolantonio and colleagues (2013, Mayo Clinic Proceedings, PMID 23597877) conducted a meta-analysis of 13 trials including 3,629 patients with prior myocardial infarction. L-carnitine supplementation reduced all-cause mortality by 27%, ventricular arrhythmias by 65%, and angina symptoms by 40%. These are not marginal effects—they represent genuine clinical benefits in a high-risk population. The mechanism involves improved energy metabolism in ischemic myocardium: carnitine facilitates fatty acid transport into mitochondria, enhancing ATP production when oxygen is limited. Shang and colleagues (2014, BMC Cardiovascular Disorders, PMID 25044037) extended this to heart failure, finding that carnitine improved cardiac function and exercise tolerance across 17 trials.
The TMAO concern emerged from elegant mechanistic work. Koeth and colleagues (2013, Nature Medicine, PMID 23563705) demonstrated that gut bacteria metabolize carnitine to trimethylamine, which the liver converts to TMAO. In mouse models, TMAO promoted atherosclerosis by enhancing macrophage cholesterol accumulation and foam cell formation. In human observational studies, higher TMAO levels correlated with cardiovascular disease risk. This created a paradox: carnitine helps hearts recover from ischemia, but may promote atherosclerosis through microbiome metabolism.
The resolution requires nuance. The TMAO effect is gut microbiome-dependent—vegetarians and vegans produce minimal TMAO from carnitine because their gut bacteria lack the requisite enzymes. The clinical outcome trials showing mortality benefit were conducted in cardiac patients, not healthy populations. The honest framing: L-carnitine has genuine benefits in post-MI recovery and heart failure, where cardiac energy metabolism is compromised. In healthy individuals without carnitine deficiency, the TMAO mechanism suggests caution, particularly for those with omnivorous diets and established cardiovascular risk factors. The risk-benefit calculus shifts dramatically based on clinical context.
Peptides are physician-only. Tell us a bit and we'll route you to the right specialist.
